Since 2007, Neurelis has been dedicated to providing solutions for unmet medical needs. To this end, we have acquired delivery technologies to enhance drug development and performance. We leverage these technologies in our own products as well as in products being developed by our partners.
Neurelis Technology Portfolio
The science of Intravail® enables the non-invasive delivery of a broad range of protein, peptide, and non-peptide drugs, including small molecules. Intravail® can be utilized via the oral, buccal, dermal, and intranasal routes of administration, providing several advantages:
Addressing sub-optimal drug absorption
Application to wide range of molecules
Small molecules, therapeutic proteins, peptides, non-peptide macromolecules (up to ~ 30KDa)
Odorless, tasteless, non-toxic, non-mutagenic, and non-irritating
Solubility in water and oils
Compatible with routine liquid formulation and dispensing processes for ease of scale-up and production
ProTek protein technology aids in stabilization that prevents the clustering of proteins and peptides, thus reducing immunogenicity. ProTek allows the creation of easily manufacturable, homogeneous, stable, aqueous or lyophilized dosage forms for therapeutics that maintain the structural integrity and physiological activity of many protein and peptide drugs. Formulations are applicable to injectable, intranasal, and other dosage forms.
Hydrogel is an absorption-enhancing water-based gel used for transdermal and transmucosal drug delivery applications. Hydrogel serves simultaneously as a delivery vehicle and absorption enhancer. In dermal applications, Hydrogel leaves the skin feeling soft without residue. The thixotropic nature of Hydrogel prevents dripping and running when dispensing, which allows the gel to self-stabilize as soon as it is applied to the affected area.